Skip to content
TheChatArchiveThe Chat Archive
gpt-3.5-turbo-0613· OpenAIAi2 WildChat-4.8M (AI2)

shorten:A recent study found that endogenous IL-10 maintained the immune tolerance of…

  1. User

    shorten:A recent study found that endogenous IL-10 maintained the immune tolerance of autoimmune cholangitis mice, while exogenous IL-10 gene therapy increased collagen deposition, accompanied by a variety of immune cell infiltration, among which, NK cells expressed granzyme increased.

  2. Assistant

    A study found that IL-10 helped manage immune tolerance in mice with autoimmune cholangitis. However, IL-10 gene therapy led to increased collagen deposition and immune cell infiltration, specifically an increase in NK cells expressing granzyme.

  3. User

    shorten:Liver fibrosis is a progressive scarring of the liver leading to cirrhosis, liver failure, and even hepatocellular carcinoma1,2. Identifying effective therapies to prevent or reverse liver fibrosis is crucial for improving patient prognosis and reducing the global burden of liver disease3. IL-10, a cytokine with immune regulation and anti-inflammatory properties, has shown promising prospects in anti-fibrosis therapy4,5. A recent study found that endogenous IL-10 maintained immune tolerance in autoimmune cholangitis mice, while exogenous IL-10 gene increased collagen deposition, accompanied by various immune cell infiltrates including NK cells6. However, our previous research has demonstrated that IL-10 has a significant inhibitory effect on CCL4-induced liver fibrosis in rats7, but its underlying mechanism is not well understood and whether it involves the immune function of NK cells has not been reported. Therefore, in this study, we used the fibrosis mouse model to further clarify the antifibrotic effect of IL-10. Consistent with previous reports8, this study verified that IL-10 gene intervention can significantly inhibit liver inflammation, reduce collagen deposition, and improve liver function in CCL4-induced fibrotic mice.

  4. Assistant

    Liver fibrosis is a serious condition that can lead to cirrhosis and liver failure. Finding effective treatments to prevent or reverse liver fibrosis is crucial. IL-10, a cytokine with anti-inflammatory properties, has shown potential as an anti-fibrosis therapy. Previous studies have found that endogenous IL-10 maintains immune tolerance in mice with autoimmune cholangitis, while exogenous IL-10 gene therapy increases collagen deposition and immune cell infiltration, including NK cells. However, the specific mechanism of IL-10's inhibitory effect on liver fibrosis and its impact on NK cell function is not well understood. In this study, we used a mouse model of fibrosis to further investigate IL-10's antifibrotic effects. Our findings confirmed that IL-10 gene intervention can effectively reduce liver inflammation, decrease collagen deposition, and improve liver function in mice with CCL4-induced fibrosis.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.